Beyond Medical Technologies Inc. (CSE:DOCT)
0.7900
+0.0600 (8.22%)
Jun 27, 2025, 3:57 PM EDT
CSE:DOCT Cash Flow Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | -0.25 | -0.29 | -0.6 | -0.84 | -2.91 | -6.52 | Upgrade
|
Depreciation & Amortization | - | - | - | - | - | 0.14 | Upgrade
|
Loss (Gain) From Sale of Assets | - | - | - | - | - | 0.01 | Upgrade
|
Loss (Gain) From Sale of Investments | - | - | - | - | - | 0.21 | Upgrade
|
Stock-Based Compensation | 0.01 | - | - | 0.12 | 0.22 | 0.01 | Upgrade
|
Provision & Write-off of Bad Debts | - | - | - | 0 | - | - | Upgrade
|
Other Operating Activities | -0.22 | -0.15 | 0.04 | - | 0.4 | 4.24 | Upgrade
|
Change in Accounts Receivable | -0 | 0 | 0 | 0.01 | -0 | 0.04 | Upgrade
|
Change in Inventory | - | - | - | - | - | -0.19 | Upgrade
|
Change in Accounts Payable | 0.21 | 0.03 | 0.02 | 0.06 | -0.01 | 0.09 | Upgrade
|
Change in Other Net Operating Assets | 0.14 | 0.3 | 0.02 | 0.02 | 0.14 | 0.14 | Upgrade
|
Operating Cash Flow | -0.1 | -0.11 | -0.53 | -0.95 | -1.4 | -1.83 | Upgrade
|
Capital Expenditures | - | - | - | - | - | -0.23 | Upgrade
|
Sale of Property, Plant & Equipment | - | - | - | - | - | 0.01 | Upgrade
|
Cash Acquisitions | - | - | - | - | - | -0.31 | Upgrade
|
Investment in Securities | - | - | - | - | - | 0.26 | Upgrade
|
Other Investing Activities | - | - | - | - | -0.47 | 0.02 | Upgrade
|
Investing Cash Flow | - | - | - | - | -0.47 | -0.26 | Upgrade
|
Short-Term Debt Issued | - | 0.03 | 0.03 | - | - | - | Upgrade
|
Total Debt Issued | - | 0.03 | 0.03 | - | - | - | Upgrade
|
Long-Term Debt Repaid | - | - | - | - | - | -0.07 | Upgrade
|
Net Debt Issued (Repaid) | - | 0.03 | 0.03 | - | - | -0.07 | Upgrade
|
Issuance of Common Stock | 0.2 | - | - | - | 2.83 | - | Upgrade
|
Other Financing Activities | - | - | - | - | -0.15 | - | Upgrade
|
Financing Cash Flow | 0.2 | 0.03 | 0.03 | - | 2.67 | -0.07 | Upgrade
|
Foreign Exchange Rate Adjustments | - | - | - | - | - | -0 | Upgrade
|
Miscellaneous Cash Flow Adjustments | 0.03 | 0.03 | 0.02 | 0.05 | 0 | - | Upgrade
|
Net Cash Flow | 0.12 | -0.05 | -0.47 | -0.89 | 0.81 | -2.16 | Upgrade
|
Free Cash Flow | -0.1 | -0.11 | -0.53 | -0.95 | -1.4 | -2.07 | Upgrade
|
Free Cash Flow Margin | - | - | - | - | - | -991.16% | Upgrade
|
Free Cash Flow Per Share | -0.01 | -0.01 | -0.07 | -0.12 | -0.19 | -0.44 | Upgrade
|
Levered Free Cash Flow | -0.57 | -0.05 | -0.26 | -0.02 | -0.36 | -1.62 | Upgrade
|
Unlevered Free Cash Flow | -0.57 | -0.05 | -0.26 | -0.02 | -0.36 | -1.61 | Upgrade
|
Change in Net Working Capital | 0.34 | -0.21 | -0.06 | -0.35 | -0.32 | 0.27 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.